Evidence map›Paper›PMID 29577365›Full record

Trial reportBritish journal of clinical pharmacology2018

Oleuropein, a component of extra virgin olive oil, lowers postprandial glycaemia in healthy subjects.

Roberto Carnevale, Romano Silvestri, Lorenzo Loffredo, Marta Novo, Vittoria Cammisotto, Valentina Castellani, Simona Bartimoccia, Cristina Nocella, Francesco Violi

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in British journal of clinical pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 1 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 1 synthesis or guideline pooled it, 122 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Roberto CarnevaleDepartment of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.
Romano SilvestriDepartment of Drug Chemistry and Technologies, Sapienza University of Rome, Rome, Italy.
Lorenzo LoffredoDepartment of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy.ORCID 0000-0002-6542-6235
Marta NovoDepartment of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy.
Vittoria CammisottoDepartment of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy.
Valentina CastellaniDepartment of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy.
Simona BartimocciaDepartment of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy.
Cristina NocellaDepartment of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.
Francesco VioliDepartment of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy.ORCID 0000-0002-6610-7068
Sapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsExtra virgin olive oil lowers postprandial glycaemia. We investigated if oleuropein, a component of extra virgin olive oil, exerts a similar effect on postprandial glycaemia and the underlying mechanism.

methodsTwenty healthy subjects were randomly allocated in a cross-over design to 20 mg oleuropein or placebo immediately before lunch. Postprandial glycaemia along with blood insulin, dipeptidyl-peptidase-4 (DPP-4) and glucagon-like peptide-1 and oxidative stress, which included soluble NADPH oxidase-derived peptide activity (sNox2-dp), 8-iso-prostaglandin-2α and platelet p47

resultsAfter 2 h, subjects who assumed oleuropein had significantly lower blood glucose, DPP-4 activity and higher insulin and glucagon-like peptide-1 compared to placebo. Furthermore, sNox2-dp, 8-iso-PGF2α and platelet p47

conclusionsThese findings indicate that oleuropein improves postprandial glycaemic profile via hampering Nox2-derived oxidative stress.

Indexed as

AdultAntioxidantsBlood GlucoseCross-Over StudiesDouble-Blind MethodFemaleHealthy VolunteersHumansHyperglycemiaIridoid GlucosidesIridoidsMaleNADPH Oxidase 2Olive OilOxidative StressPostprandial PeriodAntioxidantsBlood GlucoseCYBB protein, humanIridoid GlucosidesIridoidsNADPH Oxidase 2oleuropeinOlive OilglycaemiaNox2oleuropeinoxidative stress

Identifiers

PMID29577365
PMCPMC6005585
OpenAlexW2790316745

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.